Ad is loading...
MYINX
Price
$7.71
Change
-$0.02 (-0.26%)
Updated
Nov 15 closing price
VTPSX
Price
$129.64
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

MYINX vs VTPSX

Header iconMYINX vs VTPSX Comparison
Open Charts MYINX vs VTPSXBanner chart's image
NYLI WMC International Rsrch Eq Inv Cl
Price$7.71
Change-$0.02 (-0.26%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Idx InstlPls
Price$129.64
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
MYINX vs VTPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MYINX vs. VTPSX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYINX is a Buy and VTPSX is a Buy.

FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 442B vs. MYINX (201M). VTPSX pays higher dividends than MYINX: VTPSX (3.30) vs MYINX (1.36). MYINX was incepted earlier than VTPSX: MYINX (17 years) vs VTPSX (14 years). MYINX has a lower initial minimum investment than VTPSX: MYINX (1000) vs VTPSX (100000000). MYINX annual gain was more profitable for investors over the last year : 13.57 vs. VTPSX (10.92). VTPSX return over 5 years is better than : 15.93 vs. MYINX (14.88).
MYINXVTPSXMYINX / VTPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD7.0834.537156%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets201M442B0%
Annual Yield % from dividends1.363.3041%
Returns for 1 year13.5710.92124%
Returns for 3 years-1.09-5.8519%
Returns for 5 years14.8815.9393%
Returns for 10 years3.7429.9213%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYG2.830.07
+2.54%
Lloyds Banking Group PLC
WABC57.030.17
+0.30%
Westamerica Bancorporation
FBIZ49.82-0.11
-0.22%
First Business Financial Services
W38.22-0.57
-1.47%
Wayfair
CARM0.88-0.06
-5.93%
Carisma Therapeutics